Paul Hastings, Cooley Lead Obesity-Focused Aardvark's IPO
By Tom Zanki · February 13, 2025, 11:19 AM EST
Obesity-focused Aardvark Therapeutics Inc. began trading Thursday after pricing a $94 million initial public offering at the bottom of its range, represented by Paul Hastings LLP and underwriters' counsel Cooley LLP, joining a...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login